Head to Head Contrast: Owens & Minor (OMI) versus The Competition

Owens & Minor (NYSE:OMI) is one of 143 publicly-traded companies in the “MED PRODUCTS” industry, but how does it weigh in compared to its rivals? We will compare Owens & Minor to similar companies based on the strength of its earnings, dividends, risk, valuation, analyst recommendations, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Owens & Minor and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owens & Minor	1	2	2	0	2.20
Owens & Minor Competitors	764	3719	7518	285	2.60

Owens & Minor currently has a consensus price target of $11.60, suggesting a potential upside of 45.88%. As a group, “MED PRODUCTS” companies have a potential upside of 41.69%. Given Owens & Minor’s higher possible upside, equities research analysts plainly believe Owens & Minor is more favorable than its rivals.

Insider and Institutional Ownership

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 44.3% of shares of all “MED PRODUCTS” companies are owned by institutional investors. 3.7% of Owens & Minor shares are owned by insiders. Comparatively, 12.4% of shares of all “MED PRODUCTS” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Owens & Minor and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Owens & Minor	-3.41%	17.09%	2.47%
Owens & Minor Competitors	-26.13%	-30.12%	-6.94%

Volatility and Risk

Owens & Minor has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Owens & Minor’s rivals have a beta of 2.72, suggesting that their average stock price is 172% more volatile than the S&P 500.

Earnings and Valuation

This table compares Owens & Minor and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Owens & Minor	$10.70 billion	-$362.69 million	-1.67
Owens & Minor Competitors	$2.81 billion	$246.14 million	4.20

Owens & Minor has higher revenue, but lower earnings than its rivals. Owens & Minor is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Owens & Minor rivals beat Owens & Minor on 7 of the 13 factors compared.

Owens & Minor Company Profile

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.